• PatientsLikeMe adds research scientist and public policy expert Marni Hall to the leadership team.
  • PatientsLikeMe and Helsinn Therapeutics (U.S.) Inc. unveil findings from an online survey capturing weight loss experiences in non-small cell lung cancer (NSCLC) patients.
  • We announce a collaboration with M2Gen to give patients and researchers a more complete picture of patients’ experiences with cancer treatments and to shed new light on the factors that may affect outcomes and quality of life.
  • In the first-ever ALS virtual trial, PatientsLikeMe and The Duke ALS Clinic evaluate the potential of Lunasin, a soy peptide, to reverse symptoms in ALS patients.